Efficacy and Safety of a Novel Triple Single-Pill for Uncontrolled Hypertension

In patients with uncontrolled hypertension, a novel triple single-pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP control at 12 weeks and had a reasonable safety profile. (Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT for Systemic Arterial Hypertension [OPTION TREAT]; NCT05920005).

Authors

Institutions

Publication Details

Journal
JACC Advances
Published
2025-08-29
DOI
https://doi.org/10.1016/j.jacadv.2025.102175
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of a Novel Triple Single-Pill for Uncontrolled Hypertension

Marco Antônio Mota Gomes, Raquel Littério de Bastos, Luiz Aparecido Bortolotto, Patrícia O. Guimarães et al.
JACC Advances
Blood Pressure and Hypertension Studies
article

Efficacy and Safety of a Novel Triple Single-Pill for Uncontrolled Hypertension

Marco Antônio Mota Gomes, Raquel Littério de Bastos, Luiz Aparecido Bortolotto, Patrícia O. Guimarães, Miguel Nasser Hissa, Andréa Araújo Brandão, Flávio Danni Fuchs, Otávio Berwanger, Vagner Madrini, Fabiana G. Marcondes‐Braga, Paula Bretas Ullmann Fernandes, Murillo de Oliveira Antunes, Vivienne Carduz Castilho, Fábio Serra Silveira, João Soares Felício, Charlene Troiani do Nascimento, Érida Magaton, Mônica Camelo Pessoa de Azevedo Albuquerque, Odílson Marcos Silvestre, Maura G Lapa, Maria H Vidotti, Luiz Otávio da Silva, Camila Santos N Albuquerque, Caio A.M. Tavares, Elizabeth Do Esp Cestario, Carlos Antonio Rodrigues Terra Filho
article en

Abstract

In patients with uncontrolled hypertension, a novel triple single-pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP control at 12 weeks and had a reasonable safety profile. (Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT for Systemic Arterial Hypertension [OPTION TREAT]; NCT05920005).

JACC AdvancesVol. 4(10)
Universidade Federal do Acre (BR), The George Institute for Global Health (GB), Diabetes Australia (AU), Hospital Israelita Albert Einstein (BR), Universidade do Estado do Rio de Janeiro (BR), Fundação de Apoio a Pesquisa do Estado de Goiás (BR), Hospital de Clínicas de Porto Alegre (BR), Centro Paulista de Investigação Clinica (BR), Department of Aerospace Science and Technology (BR), Hospital Regional de Presidente Prudente (BR), Hospital Municipal São José (BR), Santa Casa de Votuporanga (BR), Centro Universitário Cesmac (BR), Hospital do Coração (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Libbs (Brazil) (BR), Universidade Federal do Pará (BR), Universidade São Francisco (BR)
Openalex Percentile: Top 64%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.